Table 1.
Encounter characteristics associated with statin and ACEI/ARB prescribing at in-person office visits at 10 community health centers in Oregon where the medication(s) was/were clinically indicateda, June 2011 to May 2014
| Office visitsb where a statin indicated | Office visitsb where an ACEI/ARB was indicated | |||||
|---|---|---|---|---|---|---|
| Number of encountersc | % with an statin Rx < = 2 days | p-value | Number of encountersc | % with an ACEI/ARBs Rx < = 2 days | p-value | |
| Total | 11588 | (13.2) | 9887 | (15.8) | ||
| Encounters | ||||||
| Diabetes encounterd | <.0001 | <.0001 | ||||
| # encounters for patient in last year with same provider | <.0001 | <.0001 | ||||
| 0 | 3114 | (14.3) | 2669 | (21.9) | ||
| 1-3 | 4345 | (16.8) | 3455 | (18.4) | ||
| > = 4 | 4129 | (8.7) | 3763 | (9.2) | ||
| # encounters for patient in last year at same clinic | <.0001 | <.0001 | ||||
| 0 | 1186 | (22.9) | 1091 | (37.2) | ||
| 1-3 | 4114 | (18.4) | 3202 | (20.5) | ||
| > = 4 | 6288 | (8.0) | 5594 | (9.0) | ||
| Diabetes encounterd | <.0001 | <.0001 | ||||
| No | 5082 | (6.2) | 4388 | (8.7) | ||
| Ye | 6506 | (18.7) | 5499 | (21.5) | ||
| Encounter provider type | 0.0003 | <.0001 | ||||
| Physician/Resident | 6810 | (12.3) | 6256 | (13.6) | ||
| PA/NP | 4778 | (14.6) | 3631 | (19.6) | ||
| Encounter provider was PCP? | <.0001 | <.0001 | ||||
| No | 2092 | (7.1) | 1672 | (10.0) | ||
| Yes | 9257 | (14.5) | 7988 | (16.8) | ||
| Missing/Unknown | 239 | (19.2) | 227 | (25.6) | ||
| Nurse touched chart in encounter? | <.0001 | 0.0007 | ||||
| No | 8383 | (12.3) | 7190 | (15.1) | ||
| Yes | 3205 | (15.6) | 2697 | (17.9) | ||
| # non-study alerts fired at encounter | 0.5615 | 0.0046 | ||||
| 0 | 2076 | (13.0) | 1681 | (17.3) | ||
| 1-2 | 6376 | (13.0) | 5650 | (14.8) | ||
| > = 3 | 3136 | (13.8) | 2556 | (17.2) | ||
Abbreviations: ACEI angiotensin-converting enzyme inhibitor, ARB angiotensin II receptor blockers; PA Physician’s Assistant, Pcp primary care provider assigned to patient, NP Nurse Practitioner
aPoint-of-care alert for specified drug class fired at the visit
bOffice visits defined as in-person encounters at a study clinic where the provider was a MD, PA, NP, or resident, and the encounter Evaluation & Management CPT code was in: 99201-99205; 99212-99215; 99243; 99385-99387; 99395-99397
cVisit counts are not mutually exclusive, e.g., if both types of BPA fired at a visit, the visit is counted in both the statin and ACEI/ARB columns. p-value from chi square test for independence between characteristic and outcome of Rx < = 2 days
dDiabetes encounter = DM listed as chief complaint or DM listed as the primary Dx for visit, or DM was the first Dx associated with visit